US Stocks
/
AnaptysBio, Inc. Share Price
AnaptysBio, Inc. Share Price

AnaptysBio, Inc. Share Price

NASDAQ: ANAB | Small Cap
$46.57
+$0.30 (0.65%) Last updated on 09 Oct, 2026 | 22:15 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

AnaptysBio, Inc. Stock Performance

Open
$46.37
Prev. Close
$46.27
Circuit Range
N/A
Day Range
$45.95 - $47.12
Year Range
$30.50 - $72.93
Volume
19,658
Average Traded
$46.53

AnaptysBio, Inc. Share Price Today

As of 9 October 2026, AnaptysBio, Inc.'s share price is $46.57. The stock opened at $46.37, compared to its previous close of $46.27. During today's trading session, AnaptysBio, Inc.'s share price traded between $45.95 and $47.12, with an average price of $46.54. Over the past 52 weeks, the stock has recorded a high of $72.93 and a low of $30.50. In terms of performance, AnaptysBio, Inc.'s share price has declined by 29.16% over the last six months and is up 27.22% on a year-on-year basis.

AnaptysBio, Inc. Share Price Chart

$45.95$47.12
L
Show Current Price
H

AnaptysBio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.34B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.90
Revenue (TTM)
$234.60B
Return On Equity (TTM)
-210.14%
Profit Margin
-5.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-36.89%

AnaptysBio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2025Sep 2025Dec 2025Mar 2026
Revenue$22.26$76.32$108.25$25.56
Net Profit-$38.63$15.11$49.61-$52.88
Net Profit Margin-173.54%19.80%45.83%-206.89%
Income ChangeN/A139.11%228.33%-206.59%

AnaptysBio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$10.29$17.16$91.28$234.60
Net Profit-$128.72-$163.62-$145.23-$13.23
Net Profit Margin-1250.92%-953.50%-159.10%-5.64%
Income ChangeN/A-27.11%11.24%90.89%

About AnaptysBio, Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

AnaptysBio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$50.98
$46.57
-7.57%
Sep 2026
$56.96
$50.38
-12.09%
Aug 2026
$51.98
$57.31
+7.57%
Jul 2026
$66.59
$53.28
-21.01%
Jun 2026
$54.54
$67.45
+21.01%
May 2026
$66.31
$55.74
-15.21%
Apr 2026
$56.16
$65.74
+18.40%
Mar 2026
$54.22
$55.52
+1.06%
Feb 2026
$47.86
$54.94
+15.88%
Jan 2026
$48.57
$47.41
-2.24%
Dec 2025
$41.94
$48.49
+16.03%
Nov 2025
$36.44
$41.80
+14.18%

ANAB Share Price FAQs

What is AnaptysBio, Inc. share price today?

chevron-up
AnaptysBio, Inc. share price today is $46.57 as on October 9, 2026 at 10:15 pm IST.

What is the 52 week high and 52 week low of AnaptysBio, Inc. stock?

chevron-up
The 52 week high of AnaptysBio, Inc. stock is $72.93, while the 52 week low is $30.50 as of 9 Oct '26.

What is ANAB's market capitalisation today?

chevron-up
ANAB market capitalisation is $1.34B as of October 9, 2026, at 10:16 pm IST.

What is ANAB's net income for the last quarter?

chevron-up
ANAB's net income for the last quarter is -52.88B USD.

What is the 5 year returns of ANAB?

chevron-up
The 5 year returns of ANAB is 41.40% as on 9 Oct '26.

What is the high & low stock price of ANAB today?

chevron-up
ANAB stock price hit a high of $47.12 and low of $45.95 as of 9 Oct '26.

Can I buy ANAB shares in India?

chevron-up
Yes. You can buy ANAB in India by opening an international trading account.